nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydrochlorothiazide—Muscular weakness—Doxorubicin—bone cancer	0.00208	0.00208	CcSEcCtD
Hydrochlorothiazide—Alanine aminotransferase increased—Doxorubicin—bone cancer	0.00208	0.00208	CcSEcCtD
Hydrochlorothiazide—Renal failure—Methotrexate—bone cancer	0.00206	0.00206	CcSEcCtD
Hydrochlorothiazide—Dysuria—Epirubicin—bone cancer	0.00206	0.00206	CcSEcCtD
Hydrochlorothiazide—Neutropenia—Epirubicin—bone cancer	0.00206	0.00206	CcSEcCtD
Hydrochlorothiazide—Abdominal distension—Doxorubicin—bone cancer	0.00205	0.00205	CcSEcCtD
Hydrochlorothiazide—Upper respiratory tract infection—Epirubicin—bone cancer	0.00205	0.00205	CcSEcCtD
Hydrochlorothiazide—Conjunctivitis—Methotrexate—bone cancer	0.00204	0.00204	CcSEcCtD
Hydrochlorothiazide—Influenza—Doxorubicin—bone cancer	0.00204	0.00204	CcSEcCtD
Hydrochlorothiazide—Dysphagia—Doxorubicin—bone cancer	0.00204	0.00204	CcSEcCtD
Hydrochlorothiazide—Pollakiuria—Epirubicin—bone cancer	0.00203	0.00203	CcSEcCtD
Hydrochlorothiazide—Sweating—Methotrexate—bone cancer	0.00201	0.00201	CcSEcCtD
Hydrochlorothiazide—Photosensitivity reaction—Epirubicin—bone cancer	0.00201	0.00201	CcSEcCtD
Hydrochlorothiazide—Feeling abnormal—Cisplatin—bone cancer	0.00201	0.00201	CcSEcCtD
Hydrochlorothiazide—Weight increased—Epirubicin—bone cancer	0.002	0.002	CcSEcCtD
Hydrochlorothiazide—Haematuria—Methotrexate—bone cancer	0.002	0.002	CcSEcCtD
Hydrochlorothiazide—Pancreatitis—Doxorubicin—bone cancer	0.002	0.002	CcSEcCtD
Hydrochlorothiazide—Hyperglycaemia—Epirubicin—bone cancer	0.00199	0.00199	CcSEcCtD
Hydrochlorothiazide—Angina pectoris—Doxorubicin—bone cancer	0.00198	0.00198	CcSEcCtD
Hydrochlorothiazide—Epistaxis—Methotrexate—bone cancer	0.00198	0.00198	CcSEcCtD
Hydrochlorothiazide—Pneumonia—Epirubicin—bone cancer	0.00197	0.00197	CcSEcCtD
Hydrochlorothiazide—Agranulocytosis—Methotrexate—bone cancer	0.00196	0.00196	CcSEcCtD
Hydrochlorothiazide—Stevens-Johnson syndrome—Epirubicin—bone cancer	0.00195	0.00195	CcSEcCtD
Hydrochlorothiazide—Renal failure—Epirubicin—bone cancer	0.00193	0.00193	CcSEcCtD
Hydrochlorothiazide—Body temperature increased—Cisplatin—bone cancer	0.00193	0.00193	CcSEcCtD
Hydrochlorothiazide—Neuropathy peripheral—Epirubicin—bone cancer	0.00192	0.00192	CcSEcCtD
Hydrochlorothiazide—Jaundice—Epirubicin—bone cancer	0.00191	0.00191	CcSEcCtD
Hydrochlorothiazide—Urinary tract infection—Epirubicin—bone cancer	0.00191	0.00191	CcSEcCtD
Hydrochlorothiazide—Conjunctivitis—Epirubicin—bone cancer	0.00191	0.00191	CcSEcCtD
Hydrochlorothiazide—Neutropenia—Doxorubicin—bone cancer	0.00191	0.00191	CcSEcCtD
Hydrochlorothiazide—Dysuria—Doxorubicin—bone cancer	0.00191	0.00191	CcSEcCtD
Hydrochlorothiazide—Upper respiratory tract infection—Doxorubicin—bone cancer	0.00189	0.00189	CcSEcCtD
Hydrochlorothiazide—Hepatitis—Methotrexate—bone cancer	0.00188	0.00188	CcSEcCtD
Hydrochlorothiazide—Sweating—Epirubicin—bone cancer	0.00188	0.00188	CcSEcCtD
Hydrochlorothiazide—Pollakiuria—Doxorubicin—bone cancer	0.00188	0.00188	CcSEcCtD
Hydrochlorothiazide—Haematuria—Epirubicin—bone cancer	0.00187	0.00187	CcSEcCtD
Hydrochlorothiazide—Pharyngitis—Methotrexate—bone cancer	0.00187	0.00187	CcSEcCtD
Hydrochlorothiazide—Photosensitivity reaction—Doxorubicin—bone cancer	0.00186	0.00186	CcSEcCtD
Hydrochlorothiazide—Weight increased—Doxorubicin—bone cancer	0.00185	0.00185	CcSEcCtD
Hydrochlorothiazide—Epistaxis—Epirubicin—bone cancer	0.00185	0.00185	CcSEcCtD
Hydrochlorothiazide—Sinusitis—Epirubicin—bone cancer	0.00184	0.00184	CcSEcCtD
Hydrochlorothiazide—Hyperglycaemia—Doxorubicin—bone cancer	0.00184	0.00184	CcSEcCtD
Hydrochlorothiazide—Agranulocytosis—Epirubicin—bone cancer	0.00183	0.00183	CcSEcCtD
Hydrochlorothiazide—Pneumonia—Doxorubicin—bone cancer	0.00183	0.00183	CcSEcCtD
Hydrochlorothiazide—Visual impairment—Methotrexate—bone cancer	0.00182	0.00182	CcSEcCtD
Hydrochlorothiazide—Stevens-Johnson syndrome—Doxorubicin—bone cancer	0.0018	0.0018	CcSEcCtD
Hydrochlorothiazide—Hypersensitivity—Cisplatin—bone cancer	0.0018	0.0018	CcSEcCtD
Hydrochlorothiazide—Bradycardia—Epirubicin—bone cancer	0.00179	0.00179	CcSEcCtD
Hydrochlorothiazide—Renal failure—Doxorubicin—bone cancer	0.00179	0.00179	CcSEcCtD
Hydrochlorothiazide—Erythema multiforme—Methotrexate—bone cancer	0.00178	0.00178	CcSEcCtD
Hydrochlorothiazide—Neuropathy peripheral—Doxorubicin—bone cancer	0.00178	0.00178	CcSEcCtD
Hydrochlorothiazide—Jaundice—Doxorubicin—bone cancer	0.00177	0.00177	CcSEcCtD
Hydrochlorothiazide—Rhinitis—Epirubicin—bone cancer	0.00177	0.00177	CcSEcCtD
Hydrochlorothiazide—Conjunctivitis—Doxorubicin—bone cancer	0.00177	0.00177	CcSEcCtD
Hydrochlorothiazide—Urinary tract infection—Doxorubicin—bone cancer	0.00177	0.00177	CcSEcCtD
Hydrochlorothiazide—Hepatitis—Epirubicin—bone cancer	0.00176	0.00176	CcSEcCtD
Hydrochlorothiazide—Tinnitus—Methotrexate—bone cancer	0.00176	0.00176	CcSEcCtD
Hydrochlorothiazide—Hypoaesthesia—Epirubicin—bone cancer	0.00175	0.00175	CcSEcCtD
Hydrochlorothiazide—Asthenia—Cisplatin—bone cancer	0.00175	0.00175	CcSEcCtD
Hydrochlorothiazide—Pharyngitis—Epirubicin—bone cancer	0.00175	0.00175	CcSEcCtD
Hydrochlorothiazide—Sweating—Doxorubicin—bone cancer	0.00174	0.00174	CcSEcCtD
Hydrochlorothiazide—Oedema peripheral—Epirubicin—bone cancer	0.00174	0.00174	CcSEcCtD
Hydrochlorothiazide—Haematuria—Doxorubicin—bone cancer	0.00173	0.00173	CcSEcCtD
Hydrochlorothiazide—Epistaxis—Doxorubicin—bone cancer	0.00171	0.00171	CcSEcCtD
Hydrochlorothiazide—Sinusitis—Doxorubicin—bone cancer	0.0017	0.0017	CcSEcCtD
Hydrochlorothiazide—Visual impairment—Epirubicin—bone cancer	0.0017	0.0017	CcSEcCtD
Hydrochlorothiazide—Agranulocytosis—Doxorubicin—bone cancer	0.0017	0.0017	CcSEcCtD
Hydrochlorothiazide—Diarrhoea—Cisplatin—bone cancer	0.00167	0.00167	CcSEcCtD
Hydrochlorothiazide—Erythema multiforme—Epirubicin—bone cancer	0.00167	0.00167	CcSEcCtD
Hydrochlorothiazide—Alopecia—Methotrexate—bone cancer	0.00166	0.00166	CcSEcCtD
Hydrochlorothiazide—Bradycardia—Doxorubicin—bone cancer	0.00166	0.00166	CcSEcCtD
Hydrochlorothiazide—Tinnitus—Epirubicin—bone cancer	0.00164	0.00164	CcSEcCtD
Hydrochlorothiazide—Erythema—Methotrexate—bone cancer	0.00164	0.00164	CcSEcCtD
Hydrochlorothiazide—Flushing—Epirubicin—bone cancer	0.00164	0.00164	CcSEcCtD
Hydrochlorothiazide—Rhinitis—Doxorubicin—bone cancer	0.00164	0.00164	CcSEcCtD
Hydrochlorothiazide—Hepatitis—Doxorubicin—bone cancer	0.00163	0.00163	CcSEcCtD
Hydrochlorothiazide—Hypoaesthesia—Doxorubicin—bone cancer	0.00162	0.00162	CcSEcCtD
Hydrochlorothiazide—Pharyngitis—Doxorubicin—bone cancer	0.00162	0.00162	CcSEcCtD
Hydrochlorothiazide—Oedema peripheral—Doxorubicin—bone cancer	0.00161	0.00161	CcSEcCtD
Hydrochlorothiazide—Dysgeusia—Methotrexate—bone cancer	0.00161	0.00161	CcSEcCtD
Hydrochlorothiazide—Back pain—Methotrexate—bone cancer	0.00159	0.00159	CcSEcCtD
Hydrochlorothiazide—Arrhythmia—Epirubicin—bone cancer	0.00157	0.00157	CcSEcCtD
Hydrochlorothiazide—Visual impairment—Doxorubicin—bone cancer	0.00157	0.00157	CcSEcCtD
Hydrochlorothiazide—Alopecia—Epirubicin—bone cancer	0.00156	0.00156	CcSEcCtD
Hydrochlorothiazide—Vomiting—Cisplatin—bone cancer	0.00155	0.00155	CcSEcCtD
Hydrochlorothiazide—Vision blurred—Methotrexate—bone cancer	0.00155	0.00155	CcSEcCtD
Hydrochlorothiazide—Erythema multiforme—Doxorubicin—bone cancer	0.00154	0.00154	CcSEcCtD
Hydrochlorothiazide—Rash—Cisplatin—bone cancer	0.00154	0.00154	CcSEcCtD
Hydrochlorothiazide—Dermatitis—Cisplatin—bone cancer	0.00154	0.00154	CcSEcCtD
Hydrochlorothiazide—Erythema—Epirubicin—bone cancer	0.00153	0.00153	CcSEcCtD
Hydrochlorothiazide—Ill-defined disorder—Methotrexate—bone cancer	0.00152	0.00152	CcSEcCtD
Hydrochlorothiazide—Tinnitus—Doxorubicin—bone cancer	0.00152	0.00152	CcSEcCtD
Hydrochlorothiazide—Anaemia—Methotrexate—bone cancer	0.00152	0.00152	CcSEcCtD
Hydrochlorothiazide—Flushing—Doxorubicin—bone cancer	0.00151	0.00151	CcSEcCtD
Hydrochlorothiazide—Flatulence—Epirubicin—bone cancer	0.00151	0.00151	CcSEcCtD
Hydrochlorothiazide—Tension—Epirubicin—bone cancer	0.00151	0.00151	CcSEcCtD
Hydrochlorothiazide—Dysgeusia—Epirubicin—bone cancer	0.0015	0.0015	CcSEcCtD
Hydrochlorothiazide—Nervousness—Epirubicin—bone cancer	0.00149	0.00149	CcSEcCtD
Hydrochlorothiazide—Back pain—Epirubicin—bone cancer	0.00148	0.00148	CcSEcCtD
Hydrochlorothiazide—Malaise—Methotrexate—bone cancer	0.00148	0.00148	CcSEcCtD
Hydrochlorothiazide—Muscle spasms—Epirubicin—bone cancer	0.00148	0.00148	CcSEcCtD
Hydrochlorothiazide—Vertigo—Methotrexate—bone cancer	0.00147	0.00147	CcSEcCtD
Hydrochlorothiazide—Leukopenia—Methotrexate—bone cancer	0.00147	0.00147	CcSEcCtD
Hydrochlorothiazide—Arrhythmia—Doxorubicin—bone cancer	0.00146	0.00146	CcSEcCtD
Hydrochlorothiazide—Nausea—Cisplatin—bone cancer	0.00145	0.00145	CcSEcCtD
Hydrochlorothiazide—Vision blurred—Epirubicin—bone cancer	0.00145	0.00145	CcSEcCtD
Hydrochlorothiazide—Alopecia—Doxorubicin—bone cancer	0.00144	0.00144	CcSEcCtD
Hydrochlorothiazide—Cough—Methotrexate—bone cancer	0.00143	0.00143	CcSEcCtD
Hydrochlorothiazide—Ill-defined disorder—Epirubicin—bone cancer	0.00142	0.00142	CcSEcCtD
Hydrochlorothiazide—Erythema—Doxorubicin—bone cancer	0.00142	0.00142	CcSEcCtD
Hydrochlorothiazide—Anaemia—Epirubicin—bone cancer	0.00142	0.00142	CcSEcCtD
Hydrochlorothiazide—Agitation—Epirubicin—bone cancer	0.00141	0.00141	CcSEcCtD
Hydrochlorothiazide—Flatulence—Doxorubicin—bone cancer	0.0014	0.0014	CcSEcCtD
Hydrochlorothiazide—Chest pain—Methotrexate—bone cancer	0.0014	0.0014	CcSEcCtD
Hydrochlorothiazide—Arthralgia—Methotrexate—bone cancer	0.0014	0.0014	CcSEcCtD
Hydrochlorothiazide—Myalgia—Methotrexate—bone cancer	0.0014	0.0014	CcSEcCtD
Hydrochlorothiazide—Tension—Doxorubicin—bone cancer	0.00139	0.00139	CcSEcCtD
Hydrochlorothiazide—Dysgeusia—Doxorubicin—bone cancer	0.00139	0.00139	CcSEcCtD
Hydrochlorothiazide—Malaise—Epirubicin—bone cancer	0.00138	0.00138	CcSEcCtD
Hydrochlorothiazide—Discomfort—Methotrexate—bone cancer	0.00138	0.00138	CcSEcCtD
Hydrochlorothiazide—Nervousness—Doxorubicin—bone cancer	0.00138	0.00138	CcSEcCtD
Hydrochlorothiazide—Vertigo—Epirubicin—bone cancer	0.00138	0.00138	CcSEcCtD
Hydrochlorothiazide—Syncope—Epirubicin—bone cancer	0.00138	0.00138	CcSEcCtD
Hydrochlorothiazide—Leukopenia—Epirubicin—bone cancer	0.00137	0.00137	CcSEcCtD
Hydrochlorothiazide—Back pain—Doxorubicin—bone cancer	0.00137	0.00137	CcSEcCtD
Hydrochlorothiazide—Muscle spasms—Doxorubicin—bone cancer	0.00136	0.00136	CcSEcCtD
Hydrochlorothiazide—Palpitations—Epirubicin—bone cancer	0.00136	0.00136	CcSEcCtD
Hydrochlorothiazide—Confusional state—Methotrexate—bone cancer	0.00135	0.00135	CcSEcCtD
Hydrochlorothiazide—Loss of consciousness—Epirubicin—bone cancer	0.00135	0.00135	CcSEcCtD
Hydrochlorothiazide—Cough—Epirubicin—bone cancer	0.00134	0.00134	CcSEcCtD
Hydrochlorothiazide—Anaphylactic shock—Methotrexate—bone cancer	0.00134	0.00134	CcSEcCtD
Hydrochlorothiazide—Vision blurred—Doxorubicin—bone cancer	0.00134	0.00134	CcSEcCtD
Hydrochlorothiazide—Ill-defined disorder—Doxorubicin—bone cancer	0.00132	0.00132	CcSEcCtD
Hydrochlorothiazide—Anaemia—Doxorubicin—bone cancer	0.00131	0.00131	CcSEcCtD
Hydrochlorothiazide—Thrombocytopenia—Methotrexate—bone cancer	0.00131	0.00131	CcSEcCtD
Hydrochlorothiazide—Chest pain—Epirubicin—bone cancer	0.00131	0.00131	CcSEcCtD
Hydrochlorothiazide—Myalgia—Epirubicin—bone cancer	0.00131	0.00131	CcSEcCtD
Hydrochlorothiazide—Arthralgia—Epirubicin—bone cancer	0.00131	0.00131	CcSEcCtD
Hydrochlorothiazide—Agitation—Doxorubicin—bone cancer	0.0013	0.0013	CcSEcCtD
Hydrochlorothiazide—Anxiety—Epirubicin—bone cancer	0.0013	0.0013	CcSEcCtD
Hydrochlorothiazide—Hyperhidrosis—Methotrexate—bone cancer	0.00129	0.00129	CcSEcCtD
Hydrochlorothiazide—Discomfort—Epirubicin—bone cancer	0.00129	0.00129	CcSEcCtD
Hydrochlorothiazide—Malaise—Doxorubicin—bone cancer	0.00128	0.00128	CcSEcCtD
Hydrochlorothiazide—Dry mouth—Epirubicin—bone cancer	0.00128	0.00128	CcSEcCtD
Hydrochlorothiazide—Vertigo—Doxorubicin—bone cancer	0.00128	0.00128	CcSEcCtD
Hydrochlorothiazide—Anorexia—Methotrexate—bone cancer	0.00128	0.00128	CcSEcCtD
Hydrochlorothiazide—Syncope—Doxorubicin—bone cancer	0.00127	0.00127	CcSEcCtD
Hydrochlorothiazide—Leukopenia—Doxorubicin—bone cancer	0.00127	0.00127	CcSEcCtD
Hydrochlorothiazide—Confusional state—Epirubicin—bone cancer	0.00126	0.00126	CcSEcCtD
Hydrochlorothiazide—Palpitations—Doxorubicin—bone cancer	0.00125	0.00125	CcSEcCtD
Hydrochlorothiazide—Oedema—Epirubicin—bone cancer	0.00125	0.00125	CcSEcCtD
Hydrochlorothiazide—Anaphylactic shock—Epirubicin—bone cancer	0.00125	0.00125	CcSEcCtD
Hydrochlorothiazide—Hypotension—Methotrexate—bone cancer	0.00125	0.00125	CcSEcCtD
Hydrochlorothiazide—Loss of consciousness—Doxorubicin—bone cancer	0.00125	0.00125	CcSEcCtD
Hydrochlorothiazide—Cough—Doxorubicin—bone cancer	0.00124	0.00124	CcSEcCtD
Hydrochlorothiazide—Shock—Epirubicin—bone cancer	0.00123	0.00123	CcSEcCtD
Hydrochlorothiazide—Thrombocytopenia—Epirubicin—bone cancer	0.00123	0.00123	CcSEcCtD
Hydrochlorothiazide—Tachycardia—Epirubicin—bone cancer	0.00122	0.00122	CcSEcCtD
Hydrochlorothiazide—Musculoskeletal discomfort—Methotrexate—bone cancer	0.00122	0.00122	CcSEcCtD
Hydrochlorothiazide—Hyperhidrosis—Epirubicin—bone cancer	0.00121	0.00121	CcSEcCtD
Hydrochlorothiazide—Insomnia—Methotrexate—bone cancer	0.00121	0.00121	CcSEcCtD
Hydrochlorothiazide—Arthralgia—Doxorubicin—bone cancer	0.00121	0.00121	CcSEcCtD
Hydrochlorothiazide—Myalgia—Doxorubicin—bone cancer	0.00121	0.00121	CcSEcCtD
Hydrochlorothiazide—Chest pain—Doxorubicin—bone cancer	0.00121	0.00121	CcSEcCtD
Hydrochlorothiazide—Anxiety—Doxorubicin—bone cancer	0.0012	0.0012	CcSEcCtD
Hydrochlorothiazide—Paraesthesia—Methotrexate—bone cancer	0.0012	0.0012	CcSEcCtD
Hydrochlorothiazide—Discomfort—Doxorubicin—bone cancer	0.00119	0.00119	CcSEcCtD
Hydrochlorothiazide—Anorexia—Epirubicin—bone cancer	0.00119	0.00119	CcSEcCtD
Hydrochlorothiazide—Dyspnoea—Methotrexate—bone cancer	0.00119	0.00119	CcSEcCtD
Hydrochlorothiazide—Somnolence—Methotrexate—bone cancer	0.00119	0.00119	CcSEcCtD
Hydrochlorothiazide—Dry mouth—Doxorubicin—bone cancer	0.00118	0.00118	CcSEcCtD
Hydrochlorothiazide—Dyspepsia—Methotrexate—bone cancer	0.00118	0.00118	CcSEcCtD
Hydrochlorothiazide—Hypotension—Epirubicin—bone cancer	0.00117	0.00117	CcSEcCtD
Hydrochlorothiazide—Confusional state—Doxorubicin—bone cancer	0.00117	0.00117	CcSEcCtD
Hydrochlorothiazide—Decreased appetite—Methotrexate—bone cancer	0.00116	0.00116	CcSEcCtD
Hydrochlorothiazide—Anaphylactic shock—Doxorubicin—bone cancer	0.00116	0.00116	CcSEcCtD
Hydrochlorothiazide—Oedema—Doxorubicin—bone cancer	0.00116	0.00116	CcSEcCtD
Hydrochlorothiazide—Fatigue—Methotrexate—bone cancer	0.00115	0.00115	CcSEcCtD
Hydrochlorothiazide—Pain—Methotrexate—bone cancer	0.00114	0.00114	CcSEcCtD
Hydrochlorothiazide—Musculoskeletal discomfort—Epirubicin—bone cancer	0.00114	0.00114	CcSEcCtD
Hydrochlorothiazide—Shock—Doxorubicin—bone cancer	0.00114	0.00114	CcSEcCtD
Hydrochlorothiazide—Thrombocytopenia—Doxorubicin—bone cancer	0.00113	0.00113	CcSEcCtD
Hydrochlorothiazide—Insomnia—Epirubicin—bone cancer	0.00113	0.00113	CcSEcCtD
Hydrochlorothiazide—Tachycardia—Doxorubicin—bone cancer	0.00113	0.00113	CcSEcCtD
Hydrochlorothiazide—Paraesthesia—Epirubicin—bone cancer	0.00112	0.00112	CcSEcCtD
Hydrochlorothiazide—Hyperhidrosis—Doxorubicin—bone cancer	0.00112	0.00112	CcSEcCtD
Hydrochlorothiazide—Dyspnoea—Epirubicin—bone cancer	0.00112	0.00112	CcSEcCtD
Hydrochlorothiazide—Somnolence—Epirubicin—bone cancer	0.00111	0.00111	CcSEcCtD
Hydrochlorothiazide—Anorexia—Doxorubicin—bone cancer	0.0011	0.0011	CcSEcCtD
Hydrochlorothiazide—Feeling abnormal—Methotrexate—bone cancer	0.0011	0.0011	CcSEcCtD
Hydrochlorothiazide—Dyspepsia—Epirubicin—bone cancer	0.0011	0.0011	CcSEcCtD
Hydrochlorothiazide—Gastrointestinal pain—Methotrexate—bone cancer	0.00109	0.00109	CcSEcCtD
Hydrochlorothiazide—Decreased appetite—Epirubicin—bone cancer	0.00109	0.00109	CcSEcCtD
Hydrochlorothiazide—Hypotension—Doxorubicin—bone cancer	0.00108	0.00108	CcSEcCtD
Hydrochlorothiazide—Fatigue—Epirubicin—bone cancer	0.00108	0.00108	CcSEcCtD
Hydrochlorothiazide—Pain—Epirubicin—bone cancer	0.00107	0.00107	CcSEcCtD
Hydrochlorothiazide—Constipation—Epirubicin—bone cancer	0.00107	0.00107	CcSEcCtD
Hydrochlorothiazide—Urticaria—Methotrexate—bone cancer	0.00106	0.00106	CcSEcCtD
Hydrochlorothiazide—Body temperature increased—Methotrexate—bone cancer	0.00106	0.00106	CcSEcCtD
Hydrochlorothiazide—Abdominal pain—Methotrexate—bone cancer	0.00106	0.00106	CcSEcCtD
Hydrochlorothiazide—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.00106	0.00106	CcSEcCtD
Hydrochlorothiazide—Insomnia—Doxorubicin—bone cancer	0.00105	0.00105	CcSEcCtD
Hydrochlorothiazide—Paraesthesia—Doxorubicin—bone cancer	0.00104	0.00104	CcSEcCtD
Hydrochlorothiazide—Dyspnoea—Doxorubicin—bone cancer	0.00103	0.00103	CcSEcCtD
Hydrochlorothiazide—Feeling abnormal—Epirubicin—bone cancer	0.00103	0.00103	CcSEcCtD
Hydrochlorothiazide—Somnolence—Doxorubicin—bone cancer	0.00103	0.00103	CcSEcCtD
Hydrochlorothiazide—Gastrointestinal pain—Epirubicin—bone cancer	0.00102	0.00102	CcSEcCtD
Hydrochlorothiazide—Dyspepsia—Doxorubicin—bone cancer	0.00102	0.00102	CcSEcCtD
Hydrochlorothiazide—Decreased appetite—Doxorubicin—bone cancer	0.00101	0.00101	CcSEcCtD
Hydrochlorothiazide—Fatigue—Doxorubicin—bone cancer	0.000999	0.000999	CcSEcCtD
Hydrochlorothiazide—Urticaria—Epirubicin—bone cancer	0.000995	0.000995	CcSEcCtD
Hydrochlorothiazide—Pain—Doxorubicin—bone cancer	0.000991	0.000991	CcSEcCtD
Hydrochlorothiazide—Constipation—Doxorubicin—bone cancer	0.000991	0.000991	CcSEcCtD
Hydrochlorothiazide—Abdominal pain—Epirubicin—bone cancer	0.00099	0.00099	CcSEcCtD
Hydrochlorothiazide—Body temperature increased—Epirubicin—bone cancer	0.00099	0.00099	CcSEcCtD
Hydrochlorothiazide—Hypersensitivity—Methotrexate—bone cancer	0.000986	0.000986	CcSEcCtD
Hydrochlorothiazide—Asthenia—Methotrexate—bone cancer	0.00096	0.00096	CcSEcCtD
Hydrochlorothiazide—Feeling abnormal—Doxorubicin—bone cancer	0.000955	0.000955	CcSEcCtD
Hydrochlorothiazide—Gastrointestinal pain—Doxorubicin—bone cancer	0.000948	0.000948	CcSEcCtD
Hydrochlorothiazide—Pruritus—Methotrexate—bone cancer	0.000947	0.000947	CcSEcCtD
Hydrochlorothiazide—Hypersensitivity—Epirubicin—bone cancer	0.000923	0.000923	CcSEcCtD
Hydrochlorothiazide—Urticaria—Doxorubicin—bone cancer	0.000921	0.000921	CcSEcCtD
Hydrochlorothiazide—Abdominal pain—Doxorubicin—bone cancer	0.000916	0.000916	CcSEcCtD
Hydrochlorothiazide—Body temperature increased—Doxorubicin—bone cancer	0.000916	0.000916	CcSEcCtD
Hydrochlorothiazide—Diarrhoea—Methotrexate—bone cancer	0.000916	0.000916	CcSEcCtD
Hydrochlorothiazide—Asthenia—Epirubicin—bone cancer	0.000898	0.000898	CcSEcCtD
Hydrochlorothiazide—Pruritus—Epirubicin—bone cancer	0.000886	0.000886	CcSEcCtD
Hydrochlorothiazide—Dizziness—Methotrexate—bone cancer	0.000885	0.000885	CcSEcCtD
Hydrochlorothiazide—Diarrhoea—Epirubicin—bone cancer	0.000857	0.000857	CcSEcCtD
Hydrochlorothiazide—Hypersensitivity—Doxorubicin—bone cancer	0.000854	0.000854	CcSEcCtD
Hydrochlorothiazide—Vomiting—Methotrexate—bone cancer	0.000851	0.000851	CcSEcCtD
Hydrochlorothiazide—Rash—Methotrexate—bone cancer	0.000844	0.000844	CcSEcCtD
Hydrochlorothiazide—Dermatitis—Methotrexate—bone cancer	0.000843	0.000843	CcSEcCtD
Hydrochlorothiazide—Headache—Methotrexate—bone cancer	0.000838	0.000838	CcSEcCtD
Hydrochlorothiazide—Asthenia—Doxorubicin—bone cancer	0.000831	0.000831	CcSEcCtD
Hydrochlorothiazide—Dizziness—Epirubicin—bone cancer	0.000828	0.000828	CcSEcCtD
Hydrochlorothiazide—Pruritus—Doxorubicin—bone cancer	0.00082	0.00082	CcSEcCtD
Hydrochlorothiazide—Vomiting—Epirubicin—bone cancer	0.000796	0.000796	CcSEcCtD
Hydrochlorothiazide—Nausea—Methotrexate—bone cancer	0.000795	0.000795	CcSEcCtD
Hydrochlorothiazide—Diarrhoea—Doxorubicin—bone cancer	0.000793	0.000793	CcSEcCtD
Hydrochlorothiazide—Rash—Epirubicin—bone cancer	0.00079	0.00079	CcSEcCtD
Hydrochlorothiazide—Dermatitis—Epirubicin—bone cancer	0.000789	0.000789	CcSEcCtD
Hydrochlorothiazide—Headache—Epirubicin—bone cancer	0.000785	0.000785	CcSEcCtD
Hydrochlorothiazide—Dizziness—Doxorubicin—bone cancer	0.000766	0.000766	CcSEcCtD
Hydrochlorothiazide—Nausea—Epirubicin—bone cancer	0.000744	0.000744	CcSEcCtD
Hydrochlorothiazide—Vomiting—Doxorubicin—bone cancer	0.000737	0.000737	CcSEcCtD
Hydrochlorothiazide—Rash—Doxorubicin—bone cancer	0.000731	0.000731	CcSEcCtD
Hydrochlorothiazide—Dermatitis—Doxorubicin—bone cancer	0.00073	0.00073	CcSEcCtD
Hydrochlorothiazide—Headache—Doxorubicin—bone cancer	0.000726	0.000726	CcSEcCtD
Hydrochlorothiazide—Nausea—Doxorubicin—bone cancer	0.000688	0.000688	CcSEcCtD
